Vaxcyte, Inc.PCVXNASDAQ
Loading
EPS Growth Recovery in ProgressRecovering
Percentile Rank33
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
-16.03%
↓ 470% vs avg
Percentile
P33
Within normal range
Streak
1 qtr
Consecutive growthRecovering
Average
-2.81%
Historical baseline
PeriodValue
Q4 2025-16.03%
Q3 2025-27.87%
Q2 2025-17.31%
Q1 20257.14%
Q4 2024-34.94%
Q3 202424.55%
Q2 2024-29.41%
Q1 202450.87%
Q4 2023-90.11%
Q3 2023-30.00%
Q2 20230.00%
Q1 202332.04%
Q4 2022-10.75%
Q3 2022-16.25%
Q2 2022-17.65%
Q1 2022-30.77%
Q4 2021-1.96%
Q3 2021-10.87%
Q2 2021-12.20%
Q1 20210.00%
Q4 20200.00%
Q3 20202.38%
Q2 202027.59%
Q1 202030.12%
Q4 201971.67%
Q3 2019-1.03%
Q2 201922.04%
Q1 20190.00%